Ocular Therapeutix, Inc.OCULNASDAQ
Loading
Enterprise value to EBITDA ratio
Latest
-6.47
↓ 149% vs avg
Percentile
P15
Within normal range
Streak
4 yr
Consecutive declineContracting
Average
13.11
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | -6.47 | -10.1% |
| 2024 | -5.88 | -60.2% |
| 2023 | -3.67 | -27.6% |
| 2022 | -2.88 | -101.7% |
| 2021 | 168.29 | +2359.8% |
| 2020 | -7.45 | -215.1% |
| 2019 | -2.36 | -8.0% |
| 2018 | -2.19 | -25.1% |
| 2017 | -1.75 | +61.3% |
| 2016 | -4.52 | - |